Last reviewed · How we verify

NCT05118464

Effect of Dual-Task Training on Pediatric Oncology Patients

Status unknown NA Last updated 12 November 2021
What this trial tests

NA trial testing Dual-task training in Cancer in 21 participants. Status unknown.

Timeline
15 September 2021
Primary endpoint
15 September 2022
15 September 2023

Quick facts

Lead sponsorAfyonkarahisar Health Sciences University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment21
Start date15 September 2021
Primary completion15 September 2022
Estimated completion15 September 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Afyonkarahisar Health Sciences University

Who can join

Adults 6 to 18, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is known that the treatment of children with cancer has negative effects on cognition, muscle strength, balance, and gait. Therefore, the aim of this study is to evaluate the effects of dual-task training, which is based on the principle of simultaneous performance of cognitive tasks and motor tasks, on muscle strength, balance, and gait.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dual-task training

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Afyonkarahisar Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05118464.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing